According to Antares Pharma's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is N/A. At the end of 2021 the company had a P/S ratio of 3.30.
Year | P/S ratio | Change |
---|---|---|
2021 | 3.30 | -25.78% |
2020 | 4.45 | -29.09% |
2019 | 6.27 | -8.29% |
2018 | 6.84 | 19.52% |
2017 | 5.72 | -17.35% |
2016 | 6.92 | 68.62% |
2015 | 4.10 | -67.88% |
2014 | 12.8 | -54.24% |
2013 | 27.9 | 31.34% |
2012 | 21.3 | 53.62% |
2011 | 13.8 | 23.97% |
2010 | 11.2 | -0.53% |
2009 | 11.2 | 152.52% |
2008 | 4.44 | -45.64% |
2007 | 8.17 | -45.47% |
2006 | 15.0 | -49.99% |
2005 | 30.0 | 50.83% |
2004 | 19.9 | 268.39% |
2003 | 5.39 | 376.18% |
2002 | 1.13 | -88.31% |
2001 | 9.69 |